Bank Of America Corp Aslan Pharmaceuticals LTD Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.36 - $0.9 $61,767 - $154,418
-171,576 Reduced 66.06%
88,146 $44,000
Q1 2022

May 16, 2022
BUY
$0.74 - $1.22 $49,242 - $81,183
66,544 Added 34.45%
259,722 $233,000
Q4 2021

Feb 08, 2022
BUY
$1.11 - $1.86 $214,427 - $359,311
193,178 New
193,178 $216,000

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ASLAN Pharmaceuticals Ltd

ASLN Quotes by TradingView
  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email